Phatisa private equity in buyout of vaccine producer Deltamune
The group is funding a management buyout of the veterinary vaccine producer as part of broader food-security investment strategy
Phatisa, the private equity group with interests in Africa-focused food and agriculture businesses, has helped fund and structure a management buyout of biotechnology company Deltamune, a manufacturer of animal vaccines.
The private equity firm said in a statement on Friday that it had partnered with Deltamune’s management to acquire 100% of the business from HL Hall & Sons Investments, for an undisclosed sum. HL Hall & Sons is a family-owned group of businesses with farming roots going back to 1890 in the Mbombela (Nelspruit) region, which operates businesses spanning fresh produce, property and financial services...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.